Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Testing effectiveness (Phase 2)Study completedNCT00354913
What this trial is testing

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Who this might be right for
GlioblastomaGliosarcoma
Duke University 21
Testing effectiveness (Phase 2)Study completedNCT00409214
What this trial is testing

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAnaplastic Astrocytoma
Light Sciences Oncology 18
Testing effectiveness (Phase 2)Ended earlyNCT05370508
What this trial is testing

Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

Who this might be right for
Recurrent GBM
SonALAsense, Inc. 8
Early research (Phase 1)Study completedNCT00401024
What this trial is testing

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)UnknownNCT00004204
What this trial is testing

Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT06917885
What this trial is testing

CUE-102 in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastomaGlioma, Malignant
David Reardon, MD 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05118776
What this trial is testing

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

Who this might be right for
Recurrent Glioblastoma
Ascletis Pharmaceuticals Co., Ltd. 136
Early research (Phase 1)Study completedNCT00946335
What this trial is testing

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00005859
What this trial is testing

Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 136
Early research (Phase 1)Study completedNCT00052780
What this trial is testing

Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+22 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04762069
What this trial is testing

Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme, Adult
CNS Pharmaceuticals, Inc. 252
Very early researchNot Yet RecruitingNCT07515924
What this trial is testing

Oral Gallium Maltolate for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Medical College of Wisconsin 8
Testing effectiveness (Phase 2)Study completedNCT00099060
What this trial is testing

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00376818
What this trial is testing

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Who this might be right for
Brain and Central Nervous System TumorsPsychosocial Effects of Cancer and Its Treatment
Case Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00045110
What this trial is testing

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more
National Cancer Institute (NCI) 136
Not applicableStudy completedNCT04143425
What this trial is testing

Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Who this might be right for
Adult GlioblastomaMagnetic Resonance ImagingBevacizimab
Ho Sung Kim 15
Early research (Phase 1)Study completedNCT00354068
What this trial is testing

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 65
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Ended earlyNCT01339039
What this trial is testing

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Who this might be right for
High Grade Glioma: Glioblastoma (GBM)High Grade Glioma: GliosarcomaAnaplastic Astrocytoma (AA)+2 more
Patrick Y. Wen, MD 26
Next Page